ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 237671 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 237671; 2) Community: the network communities that were significantly associated with the response to NSC 237671; 3) Molecule: the relationships between components within communities and NSC 237671; 4) MDR: the compounds that were significantly associated with the NSC 237671.

NSC Compound Enrichment Correlation
NSC 654509 Pirarubicin HCl 0.0016558732586581 0.56716931
NSC 670226 trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid 0.0016558732586581 0.42101727
NSC 692579 Null 0.0016558732586581 0.49083177
NSC 740 Methotrexate 0.0016558732586581 0.28930471
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.00181889981954877 0.26041482
NSC 37202 Acco Naphthol AS-BO 0.00181889981954878 0.12041337
NSC 102627 Yoshi 864 0.00189155427362374 0.46277993
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.00189155427362374 0.32205979
NSC 339578 Null 0.00189155427362374 0.43584462
NSC 675251 Null 0.00189155427362374 0.51426354
Total:97  Current:6    [First] [Prev] [Next] [Last]